Apyx Medical Corp (APYX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Sales	44.5	48.5	27.7	28.2	16.6	10.2	8.8	29.5
Sales growth	-8.3%	75.1%	-1.9%	70.0%	62.3%	16.0%	-70.1%	6.6%
Cost of sales	15.4	14.9	10.2	9.1	5.8	3.3	3.7	17.0
Gross profit	29.1	33.6	17.5	19.1	10.8	7.0	5.1	12.6
Gross margin	65.4%	69.3%	63.2%	67.6%	65.2%	68.0%	58.0%	42.5%

Other costs and expenses:
Research and development	4.5	4.3	3.9	3.7	2.5	1.9	1.0	2.2
Professional services	9.0	7.6	7.4	8.5	3.1	1.8	1.5	1.5
Salaries and related costs	18.6	17.5	14.6	14.0	9.3	6.9	7.8	7.5
Selling, general and administrative	48.1	43.7	33.7	36.2	21.8	8.7	15.5	9.9
Total other costs and expenses	105.9	48.0	75.7	40.0	25.1	20.8	16.5	19.5
Loss from operations	-23.6	-14.4	-20.1	-20.9	-14.3	-13.9	-11.4	-7.0
Operating margin	-52.9%	-29.8%	-72.5%	-73.9%	-86.0%	-135.7%	-129.2%	-23.7%
Interest income	0.2	0.0	0.2	1.4	0.6
Interest expense	0.0	0.0	0.0	0.0	-0.1	-0.1	-0.2
Other loss, net	0.5	-0.4	0.5	-0.4	-0.9
Total other loss, net	0.7	-0.4	0.7	1.0	-0.4	0.0	-0.1	1.6
Loss before income taxes	-22.9	-14.8	-19.4	-19.8	-14.7	-13.8	-11.5	-5.3
Income tax (benefit) expense	0.4	0.4	-7.5	-0.1	-3.9	-0.2	0.1	0.0
Net loss	-23.3	-15.2	-11.9	-19.7
Net loss attributable to non-controlling interest	-0.1	0.0	0.0
Net loss attributable to stockholders	-23.2	-15.2	-11.9	-19.7	62.7	-5.1	-11.6	-5.4

Loss per share:
Basic (in dollars per share)	($0.67)	($0.44)	($0.35)	($0.58)	$1.89	($0.16)	($0.15)	$0.34
Diluted (in dollars per share)	($0.67)	($0.44)	($0.35)	($0.58)	$1.83	($0.17)	($0.15)	$0.24